16-1494381-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016111.4(TELO2):c.100T>A(p.Ser34Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,612,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016111.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TELO2 | NM_016111.4 | c.100T>A | p.Ser34Thr | missense_variant | 2/21 | ENST00000262319.11 | NP_057195.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TELO2 | ENST00000262319.11 | c.100T>A | p.Ser34Thr | missense_variant | 2/21 | 1 | NM_016111.4 | ENSP00000262319 | P1 | |
TELO2 | ENST00000497339.6 | c.100T>A | p.Ser34Thr | missense_variant, NMD_transcript_variant | 2/12 | 5 | ENSP00000456383 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150904Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251244Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135834
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461380Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727000
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151022Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73750
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.100T>A (p.S34T) alteration is located in exon 2 (coding exon 1) of the TELO2 gene. This alteration results from a T to A substitution at nucleotide position 100, causing the serine (S) at amino acid position 34 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at